A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer

Articles > Abstract · 2011

Authors: Suzan YALÇIN, RÜÇHAN USLU, F. DANE, U. YILMAZ, N. ZENGIN, E. BUYUKUNAL, S. BUYUKBERBER, C. CAMCI, O. SENCAN, S. KILICKAP

JOURNAL OF CLINICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2011, vol 29, pp 474-474